Skip to main content

Biotech rockstars snag top posts at fast-growing Peninsula company

The three scientists, whose résumés include some of the Bay Area's best known biotech companies over the past 30 years, joined the genetic diseases drug company ahead of its $348 million IPO last month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.